![Irritable Bowel Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type [IBS with Diarrhea, IBS with Constipation, and Mixed IBS], Product, and Distribution Channel- Product Image](http://www.researchandmarkets.com/product_images/11426/11426843_500px_jpg/irritable_bowel_syndrome_treatment_market.jpg)
The irritable bowel syndrome (IBS) treatment market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 9.95% during 2020-2028.
The factors such as increasing prevalence of irritable bowel syndrome (IBS) diseases and rising research & development activities drive the market growth. Moreover, product innovations are expected to foster the market growth during the forecast period. However, the limited number of product availability and treatment inefficiency hinder the growth of the irritable bowel syndrome (IBS) treatment market. Additionally, in North America, medical device companies are finding difficulties in managing their operations due to the ongoing COVID-19 pandemic. Research studies published in Wolters Kluwer Health, Inc. (a US-based global leader in professional information, software solutions, and services for the health) stated that the COVID-19 pandemic is related to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with IBS and comorbid anxiety or/and depression.
The global irritable bowel syndrome (IBS) treatment market is segmented on the basis of type, product, and distribution channel. Based on type, the market is segmented into mixed IBS (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). The mixed IBS (IBS-M) segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR during 2021-2028. The irritable bowel syndrome (IBS) treatment market, based on product, is segmented into rifaximin, eluxadoline, lubiprostone, linaclotide, and others. The linaclotide segment held the largest share of the market in 2020. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the market is segmented into hospitals pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospitals pharmacies segment held the largest market share in 2020. However, the drug stores and retail pharmacies segment is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the International Foundation for Gastrointestinal Disorders are among the primary and secondary sources referred to while preparing the report on the irritable bowel syndrome (IBS) treatment market.
Reasons to Buy
The factors such as increasing prevalence of irritable bowel syndrome (IBS) diseases and rising research & development activities drive the market growth. Moreover, product innovations are expected to foster the market growth during the forecast period. However, the limited number of product availability and treatment inefficiency hinder the growth of the irritable bowel syndrome (IBS) treatment market. Additionally, in North America, medical device companies are finding difficulties in managing their operations due to the ongoing COVID-19 pandemic. Research studies published in Wolters Kluwer Health, Inc. (a US-based global leader in professional information, software solutions, and services for the health) stated that the COVID-19 pandemic is related to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with IBS and comorbid anxiety or/and depression.
The global irritable bowel syndrome (IBS) treatment market is segmented on the basis of type, product, and distribution channel. Based on type, the market is segmented into mixed IBS (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). The mixed IBS (IBS-M) segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR during 2021-2028. The irritable bowel syndrome (IBS) treatment market, based on product, is segmented into rifaximin, eluxadoline, lubiprostone, linaclotide, and others. The linaclotide segment held the largest share of the market in 2020. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the market is segmented into hospitals pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospitals pharmacies segment held the largest market share in 2020. However, the drug stores and retail pharmacies segment is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the International Foundation for Gastrointestinal Disorders are among the primary and secondary sources referred to while preparing the report on the irritable bowel syndrome (IBS) treatment market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the irritable bowel syndrome (IBS) treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global irritable bowel syndrome (IBS) treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Irritable Bowel Syndrome Treatment Market - By Type
1.3.2 Global Irritable Bowel Syndrome Treatment Market - By Product
1.3.3 Global Irritable Bowel Syndrome Treatment Market - By Distribution Channel
1.3.4 Global Irritable Bowel Syndrome Treatment Market - By Geography
2. Irritable Bowel Syndrome Treatment Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Irritable Bowel Syndrome Treatment Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Irritable Bowel Syndrome Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
5.1.2 Increasing Number of FDA Approvals and Drug Developments
5.2 Key Market Restraints
5.2.1 Limited Number of Product Availability and Treatment Inefficiency
5.2.2 Disruptive Effect of Corona Virus on the Economy
5.3 Key Market Opportunities
5.3.1 Increasing Disposable Incomes of The Population
5.3.2 Proliferation of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Development of Medical Devices for The Treatment of Irritable Bowel Syndrome
5.5 Impact Analysis
6. Irritable Bowel Syndrome Treatment Market - Global Analysis
6.1 Global Irritable Bowel Syndrome Treatment Market Revenue Forecast and Analysis
6.2 Global Irritable Bowel Syndrome Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Irritable Bowel Syndrome Treatment Market Analysis - By Type
7.1 Overview
7.2 Global Irritable Bowel Syndrome Treatment Market Share by Type 2020 & 2028 (%)
7.3 Mixed IBS (IBS-M)
7.3.1 Overview
7.3.2 Mixed IBS (IBS-M) Market Revenue and Forecast to 2028 (US$ Mn)
7.4 IBS with Diarrhea (IBS-D)
7.4.1.1 IBS with Diarrhea (IBS-D) Market Revenue and Forecast to 2028 (US$ Mn)
7.5 IBS with Constipation (IBS-C)
7.5.1.1 IBS with Constipation (IBS-C) Market Revenue and Forecast to 2028 (US$ Mn)
8. Irritable Bowel Syndrome Treatment Market Analysis - By Product
8.1 Overview
8.2 Global Irritable Bowel Syndrome Treatment Market Share by Product 2020 & 2028 (%)
8.3 Rifaximin
8.3.1 Overview
8.3.2 Rifaximin Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Eluxadoline
8.4.1 Overview
8.4.2 Eluxadoline Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Lubiprostone
8.5.1 Overview
8.5.2 Lubiprostone Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Linaclotide
8.6.1 Overview
8.6.2 Linaclotide Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Irritable Bowel Syndrome Treatment Market Analysis - By Distribution Channel
9.1 Overview
9.2 Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2020 & 2028 (%)
9.3 Hospitals Pharmacies
9.3.1 Overview
9.3.2 Hospitals Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Drug Stores and Retail Pharmacies
9.4.1 Overview
9.4.2 Drug Stores and Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10. Irritable Bowel Syndrome (IBS) Treatment Market - Geographical Analysis
10.1 North America: Irritable Bowel Syndrome (IBS) Treatment Market
10.1.1 Overview
10.1.2 North America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.1.4 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.1.5 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.1.6 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
10.1.7 US: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.1 US: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.2 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.1.7.3 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.1.7.4 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.1.8 Canada: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Canada: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.1.8.3 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.1.8.4 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.1.9 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.1.9.3 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.1.9.4 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.2 Europe: Irritable Bowel Syndrome Treatment Market
10.2.1 Overview
10.2.2 Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.2.4 Europe: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
10.2.5 Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
10.2.6 Europe: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
10.2.7 Germany: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.7.1 Germany: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.7.2 Germany: Irritable Bowel Syndrome Treatment Market, by Type 2019-2028 (USD Million)
10.2.7.3 Germany: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
10.2.7.4 Germany: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
10.2.8 UK: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.8.1 UK: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.8.2 UK: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.2.8.3 UK: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
10.2.8.4 UK: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
10.2.9 France: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.9.1 France: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.9.2 France: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.2.9.3 France: Irritable Bowel Syndrome Treatment Market, by Product 2019-2028 (USD Million)
10.2.9.4 France: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019-2028 (USD Million)
10.2.10 Italy: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.10.1 Italy: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.10.2 Italy: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.2.10.3 Italy: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.2.10.4 Italy: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.2.11 Spain: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.11.1.1 Spain: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.11.2 Spain: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.2.11.3 Spain: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.2.11.4 Spain: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.2.12 Rest of Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.12.1.1 Rest of Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.12.2 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.2.12.3 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.2.12.4 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3 Asia Pacific: Irritable Bowel Syndrome Treatment Market
10.3.1 Overview
10.3.2 Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.4 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.5 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3.6 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
10.3.7 Japan: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.7.1.1 Japan: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.7.2 Japan: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.7.3 Japan: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.7.4 Japan: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3.8 China: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.8.1.1 China: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.8.2 China: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.8.3 China: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.8.4 China: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3.9 India
10.3.9.1.1 India: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.9.2 India: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.9.3 India: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.9.4 India: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3.10 South Korea
10.3.10.1.1 South Korea: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.10.2 South Korea: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.10.3 South Korea: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.10.4 South Korea: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3.11 Australia
10.3.11.1.1 Australia: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.11.2 Australia: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.11.3 Australia: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.11.4 Australia: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.3.12 Rest of Asia Pacific
10.3.12.1.1 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.12.2 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type, 2019-2028 (USD Million)
10.3.12.3 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product, 2019-2028 (USD Million)
10.3.12.4 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market
10.4.1 Overview
10.4.2 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.4.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.4.5 Middle East and Africa: Irritable Bowel Syndrome (IBS), by Distribution Channel, 2019-2028 (USD Million)
10.4.6 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
10.4.7 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.7.1 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.7.2 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.4.7.3 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.4.7.4 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.4.8 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.8.1 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.8.2 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.4.8.3 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.4.8.4 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.4.9 UAE: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.9.1 UAE: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.9.2 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.4.9.3 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.4.9.4 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.4.10 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019-2028 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019-2028 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
10.5 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market
10.5.1 Overview
10.5.2 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.5 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.5.5.1 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
10.5.6 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.6.1 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.6.2 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
10.5.6.3 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.6.4 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.5.7 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.7.1 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.7.2 Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
10.5.7.3 Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.7.4 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.5.8 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.8.1 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.5.8.2 Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
10.5.8.3 Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
10.5.8.4 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Treatment Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Irritable Bowel Syndrome Treatment Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Ironwood Pharmaceuticals, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sebela Pharmaceuticals, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Alfasigma S.p.A.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Astellas Pharma Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 AstraZeneca
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Synthetic Biologics, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 1Key Developments
13.8 Bausch Health Companies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lannett Company Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 AbbVie Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of TermsList of Tables
Table 1. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 4. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 6. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Irritable Bowel Syndrome (IBS) Anti-Allergy Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 13. Europe Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 14. Europe Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 15. Europe Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 16. Germany Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 17. Germany Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 18. Germany Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 19. UK Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 20. UK Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 21. UK Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 22. France Irritable Bowel Syndrome Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 23. France Irritable Bowel Syndrome Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 24. France Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 25. Italy: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 26. Italy: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 28. Spain: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 29. Spain: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 34. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 37. Japan: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 38. Japan: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 39. Japan: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 40. China: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 41. China: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 42. China: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 43. India: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 44. India: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 45. India: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 46. South Korea: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 49. Australia: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 50. Australia: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 51. Australia: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 55. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 56. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 58. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 59. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 60. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 61. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 62. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 63. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 64. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 65. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 66. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 67. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 70. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done By Companies
Table 84. Glossary of Terms, Irritable Bowel Syndrome (IBS) Treatment Market
List of Figures
Figure 1. Irritable Bowel Syndrome Treatment Market Segmentation
Figure 2. Irritable Bowel Syndrome Treatment Market Segmentation, By Region
Figure 3. Irritable Bowel Syndrome Treatment Market Overview
Figure 4. Mixed IBS (IBS-M) is Expected to Show Remarkable Growth During Forecast Period
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Irritable Bowel Syndrome Treatment Market, by Geography (US$ Million)
Figure 7. Global Irritable Bowel Syndrome Treatment Market - Leading Country Markets (US$ Million)
Figure 8. Global Irritable Bowel Syndrome Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Irritable Bowel Syndrome Treatment Market - Revenue Forecast and Analysis - 2020- 2028
Figure 15. Global Irritable Bowel Syndrome Treatment Market - By Geography Forecast and Analysis - 2020- 2028
Figure 16. Market Positioning of Key Players in Global Irritable Bowel Syndrome Treatment Market
Figure 17. Global Irritable Bowel Syndrome Treatment Market Share by Type 2020 & 2028 (%)
Figure 18. Mixed IBS (IBS-M) Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. IBS with Diarrhea (IBS-D) Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. IBS with Constipation (IBS-C) Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Global Irritable Bowel Syndrome Treatment Market Share by Product 2020 & 2028 (%)
Figure 22. Rifaximin Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Eluxadoline Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Lubiprostone Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 25. Linaclotide Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2020 & 2028 (%)
Figure 28. Hospitals Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. Drug Stores and Retail Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 30. Online Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 32. North America Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 33. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
Figure 34. US: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Europe: Irritable Bowel Syndrome Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 38. Europe Irritable Bowel Syndrome Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 39. Europe: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
Figure 40. Germany: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. UK: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. France: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Italy: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Spain: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Rest of Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 47. Asia Pacific: Irritable Bowel Syndrome Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 48. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
Figure 49. Japan: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. China: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. India: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. South Korea: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. Australia: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 56. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
Figure 58. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 60. UAE: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 61. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 62. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country - Revenue (2020) (USD Million)
Figure 63. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 64. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
Figure 65. Brazil: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. Argentina: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 67. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
Figure 69. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 72. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 73. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ironwood Pharmaceuticals, Inc.
- AbbVie.
- Sebela Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Alfasigma S.p.A.
- Astellas Pharma Inc.
- AstraZeneca
- Synthetic Biologics, Inc.
- Bausch + Lomb Incorporated
- Lannett Company Inc
